Advertisement

Topics

The Michael J. Fox Foundation for Parkinson's Research Company Profile

04:00 EDT 22nd March 2019 | BioPortfolio

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The Foundation has funded almost $196 million in research to date.


News Articles [1795 Associated News Articles listed on BioPortfolio]

The Michael J Fox Foundation for Parkinson’s Research

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with to Debi Brooks, Co-Founder of The Michael J Fox Foundation for Parkinson’s Research They discuss the foundation's...

IBM, Michael J. Fox Foundation to research Parkinson’s using AI

IBM is planning to use AI and machine learning to better understand Parkinson’s disease after being awarded a grant from the Michael J. Fox Foundation for Parkinson’s Research.

Startup tests Parkinson's device with Michael J. Fox Foundation funding

(University of Delaware) A Mid-Atlantic research team with roots at the University of Delaware has received a $440,000 grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to test ...

Milestone Moment: A Parkinson’s Drug Moves Forward With Help From Michael J.Fox

Today, at a medical conference being hosted by the Michael J. Fox Foundation, a biotechnology is presenting the first human data from a Parkinson’s drug that several of the world’s largest drug co...

Study looks for DNA changes to measure Parkinson's disease

(University of California - San Diego) Researchers at UC San Diego and Arizona State University have received $1.7 million in funding from the Michael J. Fox Foundation for Parkinson's Research to la...

Progenra Inc. Receives Therapeutic Pipeline Award from The Michael J. Fox Foundation for Parkinson’s Research and Drug Development

Funding will support Progenra’s development of small molecules for treatment of Parkinson’s Disease Progenra Inc. announces the receipt of a 2018 Therapeutic Pipeli...

04.23.12 -- Sanofi And Michael J. Fox Foundation Collaborate On Potential New Parkinson's Treatment

04/23/12 Bioresearch Online Newsletter

AC Immune Awarded Third Follow-up Grant from The Michael J. Fox Foundation for First-in-Human Study of a Positron Emission Tomography (PET) Tracer for Parkinson's Disease

Grant supports next step in development of potentially first alpha-synuclein PET tracer for Parkinson's diseaseStart of first-in-human study of current lead is scheduled for Q1 2019Follow-up grant ma...

PubMed Articles [1771 Associated PubMed Articles listed on BioPortfolio]

Meet Your President: Michael W. Fried M.D., FAASLD.

It is a pleasure for me to introduce Dr. Michael Fried (Mike) to the membership of AASLD and others in the world of liver disease, although Mike is already very well known to many because of his exten...

Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).

To determine the feasibility, safety and tolerability of lumbar punctures (LPs) in research participants with early Parkinson disease (PD), subjects without evidence of dopaminergic deficiency (SWEDDs...

Organocatalyzed Asymmetirc Dearomative Aza-Michael/Michael Addition Cascade of 2-Nitrobenzofurans and 2-Nitrobenzothiophenes with 2-Aminochalcones.

An organocatalyzed dearomative aza-Michael/Michael addition cascade of 2-nitrobenzofurans and 2- nitrobenzothiophenes with 2-aminochalcones has been developed, opening a new channel to access a series...

A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey.

Pain is frequent in Parkinson's disease (PD) and Parkinson-plus syndrome. This study aimed to assess the prevalence, characteristics, therapy (especially the effect of dopaminergic therapy), and assoc...

Retinal α-synuclein deposits in Parkinson's disease patients and animal models.

Despite decades of research, accurate diagnosis of Parkinson's disease remains a challenge, and disease-modifying treatments are still lacking. Research into the early (presymptomatic) stages of Parki...

Clinical Trials [2770 Associated Clinical Trials listed on BioPortfolio]

Multi-chip Meta-analysis of Parkinson's Disease for Clinical Validation of Small Samples of Key Genes in Disease

The research team used meta-analytical statistical methods to integrate the results of different research groups on Parkinson's disease, using meta-analysis to find key genes related to th...

Parkinson's Disease Registry of the Muhammad Ali Parkinson Center

The purpose of the Parkinson’s disease Registry is to develop a national and international database of persons with Parkinson’s disease (PD). The Registry will be used to facilitate t...

Molecular Epidemiology of Parkinson's Disease

The aim of this research is to discover genes which modify risk for Parkinson's disease. The study includes 800 patients with Parkinson's disease, and their estimated 1,222 available sibli...

Alpha-1 Foundation Research Registry

The Alpha-1 Foundation Research Registry is a confidential database made up of individuals diagnosed with severe alpha-1 antitrypsin deficiency (Alpha-1) or the carrier state.

Genetic Influences on Response to Gait Rehabilitation in Parkinson's Disease

The aging Veteran population, together with high exposure to Agent Orange or other herbicides during military service, has made diseases such as Parkinson's disease (PD), currently affecti...

Companies [2775 Associated Companies listed on BioPortfolio]

The Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The F...

Michael J. Fox Foundation

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within the coming decade through an aggressively fund...

The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research

The Michael Stern Parkinson's Research Foundation

Brian Grant Foundation

Established in 2010, the Brian Grant Foundation supports efforts to build awareness and education of Parkinson's disease in order to increase earlier diagnosis, educate patients and their families, an...

More Information about "The Michael J. Fox Foundation for Parkinson's Research" on BioPortfolio

We have published hundreds of The Michael J. Fox Foundation for Parkinson's Research news stories on BioPortfolio along with dozens of The Michael J. Fox Foundation for Parkinson's Research Clinical Trials and PubMed Articles about The Michael J. Fox Foundation for Parkinson's Research for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Michael J. Fox Foundation for Parkinson's Research Companies in our database. You can also find out about relevant The Michael J. Fox Foundation for Parkinson's Research Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...


Corporate Database Quicklinks



Searches Linking to this Company Record